GET THE APP
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Select your language of interest to view the total content in your interested language
Clinical Pharmacology & Biopharmaceutics strictly complies with the moral justice and ethics, and would likewise direct a lawful audit if required on cases. The journal guarantees reproducing or promoting does not impact the decision of the editors. There are committed to publishing and commonly circulating high-quality content and it is a member of committee on publication ethics International Committee of Medical Journal Editors (ICMJE). It is critical that the editorial operations of this journal be governed by rigorous ethical standards that are both transparent and fair. We recognize academic publishing ecosystem composite and includes editors, authors, reviewers, and publishers. Journal follows the International Committee of Medical Journal Editor’s (ICMJE) platform to conduct and best practice guidelines for journal. Editors are not necessarily well qualified to make such judgements unassisted, and so we reserve the right to take expert advice in cases where we believe that concerns may arise. We recognize the widespread view that openness in science helps to alert society to potential threats and to defend against them, and we anticipate that very rarely (if at all) will the risks be perceived as outweighing the benefits of publishing a paper that has otherwise been deemed appropriate for the Portfolio of journal. Though, we think it is appropriate to consider such risks and to have a formal policy for dealing with them if need arises.
Duties of Editors:
Editors evaluate submitted manuscripts exclusively on the basis of their academic merit importance, originality, study’s validity, clarity and its relevance to the journal’s scope, without regard to the author’s race, ethnic origin, citizenship, religious belief, political philosophy or institutional affiliation. Decisions to edit and publish are not determined by the policies of governments or any other agencies outside of the journal. As in all publishing decisions, the ultimate decision whether to publish is the responsibility of the editor of the journal concerned. Authors of any paper describing agents or technologies whose misuse may pose a risk must complete the dual use research of concern section. This provides an opportunity not only to highlight potential hazards, but also to explain the precautions that have been taken and the benefits of publishing the research. The Reporting Summary is made available to editors, reviewers and expert advisors during manuscript assessment, and is published with all accepted manuscripts.
The editors ensure that all submitted manuscripts being considered for publication undergo a Single-blind peer-review process by at least two reviewers who are experts in the field. Editor-in Chief is responsible for deciding of manuscripts submitted to the journal will be published, based on the validation of the work in question, its importance to researchers and readers, the reviewers’ comments, and such legal requirements as are currently in force regarding vilification, copyright infringement and plagiarism. The Editor-in-Chief may confer with other editors or reviewers in making this decision.
Editors and editorial staff will not disclose any information about a submitted manuscript to other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate. We have established an editorial monitoring group to oversee the consideration of papers with biosecurity concerns. The monitoring group includes the editor-in-chief of the journal, the head of editorial policy is responsible for maintaining a network of advisors on biosecurity issues.
Standards of objectivity:
Reviews should be conducted objectively and observations formulated clearly with supporting arguments so that authors can use them for improving the manuscript. Personal censure of the authors is inappropriate.
Disclosure and conflicts of interest:
Editors and editorial board members will published information disclosed in a submitted manuscript for their own research purposes without the authors’ explicit written consent. Privileged information or ideas obtained by editors as a result of handling the manuscript will be kept confidential and not used for their personal advantage. Editors will recuse themselves from considering manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships/connections with any of the authors, companies, or institutions connected to the papers; instead, they will ask another member of the editorial board to handle the manuscript.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals